Voyages et VIH: les points-clés [Key aspects regarding HIV and travel].

Détails

ID Serval
serval:BIB_7CC2FC9BEAA3
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Voyages et VIH: les points-clés [Key aspects regarding HIV and travel].
Périodique
Revue Médicale Suisse
Auteur(s)
Gardiol C., Cavassini M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2013
Volume
9
Numéro
385
Pages
963-967
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Résumé
The risk of contracting a sexually transmitted infection while traveling abroad is increased in certain populations. Pre-travel consultation should include the education of travelers on the prevalence of HIV in the countries visited and on appropriate prevention measures. In patients infected with HIV (PHIV), combined antiretroviral therapy (cART) improves immunity, enabling them to travel with less risk for their health. Pre-travel consultation of PVIH has the following objectives: to determine immune status, to update immunization and to decide on anti-malaria drug prophylaxis, taking into account potential drug interactions with antiretroviral therapy. Vaccine response and duration of protection is shorter-lived in PVIH, especially if the CD4 count is below 200 cells/mm3 and the HIV viral load is detectable. Therefore cART is a cornerstone for disease prevention among patients infected with HIV who travel.
Mots-clé
HIV Infections/complications, HIV Infections/prevention & control, Humans, Practice Guidelines as Topic, Risk Factors, Travel
Pubmed
Création de la notice
19/09/2013 21:16
Dernière modification de la notice
03/03/2018 18:38
Données d'usage